Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects

PURPOSE: Empagliflozin is a sodium-glucose cotransporter 2 inhibitor that is commonly used for the treatment of type 2 diabetes mellitus. As cocrystal formulation can improve the chemical properties of drugs, CKD-370 was newly developed as a cocrystal formulation of empagliflozin with solvate L-prol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xu, Bae, Sungyeun, Yoon, Deok Yong, Park, Shin Jung, Oh, Jaeseong, Cho, Joo-Youn, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377562/
https://www.ncbi.nlm.nih.gov/pubmed/37521035
http://dx.doi.org/10.2147/DDDT.S409368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377562/
https://www.ncbi.nlm.nih.gov/pubmed/37521035
http://dx.doi.org/10.2147/DDDT.S409368

Ejemplares similares